-
Van den Berghe et al have recently reported the results of intensive insulin therapy (IIT) on morbidity and mortality in medical intensive care unit patients.
-
Systemic and pulmonary inflammation are key in the development and progression of the acute respiratory distress syndrome (ARDS). Lack of improvements in inflammatory markers and in the lung injury score (LIS) by day 7 are associated with higher mortality.
-
Several studies have suggested that procalcitonin may be a useful biochemical marker to differentiate sepsis from other, non-infectious, causes of the systemic inflammatory response syndrome (SIRS), such as pancreatitis.
-
Although prognostic information is viewed as very important to family members of incapacitated, critically ill patients, little is known about what prognostic information clinicians provide during family conferences.
-
This pilot study from the Medical and Coronary ICUs at Vanderbilt University Medical Center sought to identify factors associated with the development of symptoms of post-traumatic stress disorder (PTSD) following critical illness.
-
The ECG Figure in the article was obtained from an older woman who was seen in the Emergency Department with a chief complaint of weakness of several days duration.
-
Patients at high risk for VTE should be treated with three times daily UH, while patients at lower risk may be treated with twice daily therapy.
-
For women, up to 20% of all coronary events occur in the absence of traditional major risk factors, and many women with these risk factors do not develop coronary events.
-
-
Torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, has been in development by Pfizer for nearly 15 years.